These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 32606611)
1. Berberine Attenuates Arterial Plaque Formation in Atherosclerotic Rats with Damp-Heat Syndrome via Regulating Autophagy. Ke X; Huang Y; Li L; Xin F; Xu L; Zhang Y; Zeng Z; Lin F; Song Y Drug Des Devel Ther; 2020; 14():2449-2460. PubMed ID: 32606611 [TBL] [Abstract][Full Text] [Related]
2. Berberine mitigates IL-21/IL-21R mediated autophagic influx in fibroblast-like synoviocytes and regulates Th17/Treg imbalance in rheumatoid arthritis. Dinesh P; Rasool M Apoptosis; 2019 Aug; 24(7-8):644-661. PubMed ID: 31111379 [TBL] [Abstract][Full Text] [Related]
3. Myocardial hypertrophy is improved with berberine treatment via long non-coding RNA MIAT-mediated autophagy. Zeng Z; Pan Y; Wu W; Li L; Wu Z; Zhang Y; Deng B; Wei S; Zhang W; Lin F; Song Y J Pharm Pharmacol; 2019 Dec; 71(12):1822-1831. PubMed ID: 31612504 [TBL] [Abstract][Full Text] [Related]
4. Berberine protects against ischemia/reperfusion injury after orthotopic liver transplantation via activating Sirt1/FoxO3α induced autophagy. Lin Y; Sheng M; Weng Y; Xu R; Lu N; Du H; Yu W Biochem Biophys Res Commun; 2017 Feb; 483(2):885-891. PubMed ID: 28077277 [TBL] [Abstract][Full Text] [Related]
5. Berberine-sonodynamic therapy induces autophagy and lipid unloading in macrophage. Kou JY; Li Y; Zhong ZY; Jiang YQ; Li XS; Han XB; Liu ZN; Tian Y; Yang LM Cell Death Dis; 2017 Jan; 8(1):e2558. PubMed ID: 28102849 [TBL] [Abstract][Full Text] [Related]
6. Comparative effect of berberine and its derivative 8-cetylberberine on attenuating atherosclerosis in ApoE Feng M; Zou Z; Zhou X; Hu Y; Ma H; Xiao Y; Li X; Ye X Int Immunopharmacol; 2017 Feb; 43():195-202. PubMed ID: 28024280 [TBL] [Abstract][Full Text] [Related]
8. Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement. Zhou H; Feng L; Xu F; Sun Y; Ma Y; Zhang X; Liu H; Xu G; Wu X; Shen Y; Sun Y; Wu X; Xu Q Biomed Pharmacother; 2017 May; 89():864-874. PubMed ID: 28282788 [TBL] [Abstract][Full Text] [Related]
9. Protective effect of berberine against LPS-induced endothelial cell injury via the JNK signaling pathway and autophagic mechanisms. Guo J; Chen W; Bao B; Zhang D; Pan J; Zhang M Bioengineered; 2021 Dec; 12(1):1324-1337. PubMed ID: 33896366 [TBL] [Abstract][Full Text] [Related]
10. [Protective effect and immune mechanism of berberine on cerebral ischemia/reperfusion injury in rats]. Sun K; Luo ZL; Hu C; Gong TL; Tang GH; Wu SP Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Nov; 36(6):656-661. PubMed ID: 33719277 [No Abstract] [Full Text] [Related]
11. Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(-/-) mice. Chen J; Cao J; Fang L; Liu B; Zhou Q; Sun Y; Wang Y; Li Y; Meng S J Transl Med; 2014 Nov; 12():326. PubMed ID: 25425200 [TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of berberine using bionic nanomaterials for Atherosclerosis therapy. Wu H; Zhang L; Dong X; Yang J; Zheng L; Li L; Liu X; Jin M; Zhang P Biomed Pharmacother; 2024 Sep; 178():117135. PubMed ID: 39047421 [TBL] [Abstract][Full Text] [Related]
13. Berberine prevents against myocardial injury induced by acute β-adrenergic overactivation in rats. Yang Y; Jiang S; Mu Y; Liu C; Han Y; Jiang J; Wang Y J Appl Toxicol; 2024 Nov; 44(11):1700-1713. PubMed ID: 38981847 [TBL] [Abstract][Full Text] [Related]
14. Berberine alleviates cisplatin-induced acute kidney injury by regulating mitophagy via PINK 1/Parkin pathway. Qi J; Xue Q; Kuang L; Xie L; Luo R; Nie X Transl Androl Urol; 2020 Aug; 9(4):1712-1724. PubMed ID: 32944532 [TBL] [Abstract][Full Text] [Related]
15. Berberine activates peroxisome proliferator-activated receptor gamma to increase atherosclerotic plaque stability in Apoe Li H; He C; Wang J; Li X; Yang Z; Sun X; Fang L; Liu N J Diabetes Investig; 2016 Nov; 7(6):824-832. PubMed ID: 27181586 [TBL] [Abstract][Full Text] [Related]
16. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway. Wang L; Jia Z; Wang B; Zhang B Turk J Gastroenterol; 2020 Dec; 31(12):902-909. PubMed ID: 33626003 [TBL] [Abstract][Full Text] [Related]
17. The anti-atherogenic effects of berberine on foam cell formation are mediated through the upregulation of sirtuin 1. Chi L; Peng L; Pan N; Hu X; Zhang Y Int J Mol Med; 2014 Oct; 34(4):1087-93. PubMed ID: 25069720 [TBL] [Abstract][Full Text] [Related]
18. Berberine mitigates diclofenac-induced intestinal mucosal mechanical barrier dysfunction through the restoration of autophagy by inhibiting exosome-mediated lncRNA H19. He R; Li Y; He Y; Wang Q; Zhang S; Chen S Inflammopharmacology; 2024 Aug; 32(4):2525-2540. PubMed ID: 38758516 [TBL] [Abstract][Full Text] [Related]
19. Berberine as a novel ACSL4 inhibitor to suppress endothelial ferroptosis and atherosclerosis. Hong Y; Feng J; Dou Z; Sun X; Hu Y; Chen Z; Liu L; Xu H; Du M; Tang P; Liu X; Zhang Y Biomed Pharmacother; 2024 Aug; 177():117081. PubMed ID: 38971008 [TBL] [Abstract][Full Text] [Related]
20. Berberine Influences the Survival of Fat Grafting by Inhibiting Autophagy and Apoptosis of Human Adipose Derived Mesenchymal Stem Cells. Pang H; Zhou Y; Wang J; Wu H; Liu X; Gao F; Xiao Z Drug Des Devel Ther; 2021; 15():4795-4809. PubMed ID: 34876804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]